Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; Regulation by Ets in Jurkat T cells

Journal of Cellular Biochemistry

Volumn 72, Issue 4, 1999, Pages 492-506

  Gagnon, Michael L ^a   Moy, Grace K ^a   Klagsbrun, Michael ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antisense RNA; Ets; FGF 2; Jurkat; Promoter

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LUCIFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE ISOLATION; HUMAN; HUMAN CELL; LYMPHOID CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; XENOPUS;

ANIMALS; BASE SEQUENCE; BINDING SITES; CLONING, MOLECULAR; DNA, ANTISENSE; DNA-BINDING PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RNA, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; XENOPUS;

EID: 0033560034     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990315)72:4<492::AID-JCB5>3.0.CO;2-H     Document Type: Article

References (60)

1. Abraham JA, Klagsbrun M. 1996. Modulation of wound repair by members of the fibroblast growth factor family. In: Clark RAF, editor. The molecular and cellular biology of wound repair. New York: Plenum. p 195-248.
2. Baird A, Bohlen P. 1990. Fibroblast growth factors. In: Sporn MB, Roberts AB, editors. Handbook of experimental pharmacology. Vol 95: Peptide growth factors and their receptors. I. Berlin: Springer-Verlag. p 369-418.
3. Basilico C, Moscatelli D. 1992. The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165.
4. Becker D, Meier CB, Herlyn M. 1989. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO 8:3685-3691.
5. Biesiada E, Razandi M, Levin ER. 1996. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J Biol Chem 271: 18576-18581.
6. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. 1997. Biological roles of fibroblast growth factor-2. Endocr Rev 18:26-45.
7. Blackwell TK, Weintraub H. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110.
8. + T cells. Proc Natl Acad Sci USA 91:2890-2894.
9. Bories J-C, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, Stehelin D, Alt FW. 1995. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377:635-638.
10. Borja AZM, Meigers C, Zeller R. 1993. Expression of alternatively spliced bFGF first coding exons and antisense mRNAs during chicken embryogenesis. Dev Biol 157:110-118.
11. Chen CY, Schwartz RJ. 1995. Identification of novel DNA binding targets and regulatory domains of a murine tinman homeodomain factor, nkx-2.5. J Biol Chem 270: 15628-15633.
12. Chen X, Raab G, Deutsch U, Zhang J, Ezzell RM , Klagsbrun M. 1995. Induction of heparin-binding EGF-like growth factor expression during myogenesis. J Biol Chem 270:18285-18294.
13. Denhardt DT. 1992. Mechanism of action of antisense RNA. Sometime inhibition of transcription, processing, transport, or translation. Ann NY Acad Sci 660:70-76.
14. Denny P, Swift S, Connor F, Ashworth A. 1992. An SRY-related gene expressed during spermatogenesis in the mouse encodes a sequence-specific DNA-binding protein. EMBO 11:3705-3712.
15. Erdos G, Lee YJ, Cho JM , Corry PM. 1995. Heat-induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP-1 binding activity. J Cell Physiol 164:404-413.
16. Fox JC, Shanley JR. 1996. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem 271:12578-12584.
17. Graeven U, Rodeck U, Weinmann R, Herlyn M. 1992. Stable transfection of human malignant melanoma cells with basic fibroblast growth factor antisense cDNA. Ann NY Acad Sci 660:293-294.
18. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I, Fuks Z. 1994. Protein kinase C mediates basic flbroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 54:2591-2597.
19. Harley VR, Lovell-Badge R, Goodfellow PN. 1994. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 22:1500-1501.
20. Johnson PF, Williams SC. 1994. CCAAT/enhancer binding (C/EBP) proteins. In: Tronce F, Yaniz M, editors. Liver gene expression. Austin: RG Landes, p 231-258.
21. Jolliff K, Li Y, Johnson LF. 1991. Multiple protein-DNA interactions in the TATAA-less mouse thymidylate synthase promoter. Nucleic Acids Res 19:2267-2274.
22. Kimelman D, Kirschner MW. 1989. An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell 59:687-696.
23. Knee R, Li AW, Murphy PR. 1997. Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein. Proc Natl Acad Sci USA 94:4943-4947.
24. Knee R, Murphy PR. 1997. Regulation of gene expression by natural antisense RNA transcripts. Neurochem Int 31:379-392.
25. Knee RS, Pitcher SE, Murphy PR. 1994. Basic fibroblast growth factor sense (FGF) and antisense (GFG) RNA transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues. Biochem Biophys Res Commun 205:577-583.
26. Lambert PF, Ludford-Menting MJ, Deacon NJ, Kola I, Doherty RR. 1997. The nfkb1 promoter is controlled by proteins of the Ets family. Mol Biol Cell 8:313-323.
27. Li AW, Seyoum G, Shiu RPC, Murphy PR. 1996a. Expression of the rat BFGF antisense RNA transcript is tissue-specific and developmentally regulated. Mol Cell Endocrinol 118:113-123.
28. Li AW, Too CK, Knee R, Wilkinson M, Murphy PR. 1997. FGF-2 antisense RNA encodes a nuclear protein with MutT-like antimutator activity. Mol Cell Endocrinol 133: 177-182.
29. Li AW, Too CKL, Murphy PR. 1996b. The basic fibroblast growth factor (FGF-2) antisense RNA (GFG) is translated into a MutT-related protein in vivo. Biochem and Biophys Res Commun 223:19-23.
30. Lo K, Landau NR, Smale ST. 1991. Lyf-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol Cell Biol 11:5229-5243.
31. Malik KTA, Wallace JI, Ivins SM, Brown KW. 1995. Identification of an antisense WT1 promoter in intron 1: Implications for WT1 gene regulation. Oncogene 1:1589-1595.
32. Maret A, Galy B, Arnaud E, Bayard F, Prats H. 1995. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res 55:5075-5079.
33. Merika M , Orkin SH. 1993. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 13:3999-4010.
34. Moore JW, Dionne C, Jaye M, Swain JL. 1991. The mRNAs encoding acidic FGF, basic FGF and FGF receptor are coordinately downregulated during myogenic differentiation. Development 111:741-748.
35. Morrison RS. 1991. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266:728-734.
36. Murphy PR, Guo JZ, Friesen HG. 1990. Messenger RNA stabilization accounts for elevated basic fibroblast growth factor transcript levels in a human astrocytoma cell line. Mol Endocinol 4:196-200.
37. Murphy PR, Knee RS. 1994. Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene. Mol Endocrinol 8:852-859.
38. Muthusamy N, Barton K, Leiden JM. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377:639-642.
39. Noguchi M, Miyamoto S, Silverman TA, Safer B. 1994. Characterization of an antisense Inr element in the eIF-2a gene. J Biol Chem 269:29161-29167.
40. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ. 1992. Interaction of murine Ets-1 with GGA-binding sites establishes the Ets domain as a new DNA-binding motif. Genes Dev 6:975-990.
41. Payson RA, Canatan H, Chotani MA, Wang W-P, Harris SE, Myers RL, Chiu I-M. 1993. Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA. Nucleic Acids Res 21:489-495.
42. Peifley KA, Alberts GF, Hsu DKW, Feng S-LY, Winkles JA. 1996. Heparin-binding epidermal growth factor-like growth factor regulates fibroblast growth factor-2 expression in aortic smooth muscle cells. Circ Res 79:263-270.
43. Powell PP, Finklestein SP, Dionne CA, Jaye M, Klagsbrun M. 1991. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells. Mol Brain Res 11:71-77.
44. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA, Caput D. 1989. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 86:1836-1840.
45. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
46. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-termination inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
47. Sato Y, Hamanaka R, Ono J, Kuwano M, Rifkin DB, Takaki R. 1991. The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. Biochem Biophys Res Commun 174:1260-1266.
48. Savage MP, Fallen JF. 1995. FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros. Dev Dynam 202:343-353.
49. Shibata F, Baird A, Florkiewicz RZ. 1991. Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 4:277-287.
50. Silverman TA, Noguchi M, Safer B. 1992. Role of sequences within the first intron in the regulation of expression of eukaryotic initiation factor 2a. J Biol Chem 267:9738-9742.
51. Spicer DB, Sonenshein GE. 1992. An antisense promoter of the murine c-myc gene is localized within intron 2. Mol Cell Biol 12:1324-1329.
52. Stachowiak MK, Moffett J, Joy A, Puchacz E, Florkiewicz R, Stachowiak EW. 1994. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J Cell Biol 127:203-223.
53. Tamm I, Kikuchi T, Zychlinsky A. 1991. Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c 3T3 murine fibroblasts. Proc Natl Acad Sci USA 88:3372-3376.
54. Tymms MJ, Kola I. 1994. Regulation of gene expression by transcription factors Ets-1 and Ets-2. Mol Reprod Dev 39:208-214.
55. Volk R, Koster M, Poting A, Hartmann L, Knochel W. 1989. An antisense transcript from the Xenopus laevis bFGF gene coding for an evolutionarily conserved 24 kd protein. EMBO 8:2983-2988.
56. Walike PA, Cowan WM, Ueno N, Baird A, Guillemin R. 1986. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neunte extension. Proc Natl Acad Sci USA 83:3012-3016.
57. Wang D, Mayo MW, Baldwin Jr AS. 1997. Basic fibroblast growth factor transcriptional autoregulation requires EGR-1. Oncogene 14:2291-2299.
58. Wasylyk B, Hahn SL, Giovane A. 1993. The Ets family of transcription factors. Eur J Biochem 211:7-18.
59. White EM, Shapiro DL, Allis CD, Gorovsky MA. 1988. Sequence and properties of the message encoding Tetrahymena hv1, a highly evolutionarily conserved histone H2A variant that is associated with active genes. Nucleic Acids Res 16:179-198.
60. Winkles JA, Gay CG. 1991. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin-binding (acidic and basic fibroblast) growth factor gene expression in human vascular smooth muscle cells. Cell Growth Diff 2:531-540.